Compile Data Set for Download or QSAR
Report error Found 140 Enz. Inhib. hit(s) with all data for entry = 10224
TargetVasopressin V1a receptor(Human)
Bayer Pharma Aktiengesellschaft

US Patent
LigandPNGBDBM521144(US11149023, Example 39)
Affinity DataIC50: 0.480nMAssay Description:The identification of agonists and antagonists of the V1a and V2 vasopressin receptors from humans, rats and dogs as well as the quantification of th...More data for this Ligand-Target Pair
In Depth
Date in BDB:
3/13/2022
Entry Details
Go to US Patent

TargetVasopressin V1a receptor(Human)
Bayer Pharma Aktiengesellschaft

US Patent
LigandPNGBDBM521168(N-{3-[3-(4-Chlorophenyl)-5-oxo-1-({1-[3-(trifluoro...)
Affinity DataIC50: 0.720nMAssay Description:The identification of agonists and antagonists of the V1a and V2 vasopressin receptors from humans, rats and dogs as well as the quantification of th...More data for this Ligand-Target Pair
In Depth
Date in BDB:
3/13/2022
Entry Details
Go to US Patent

TargetVasopressin V1a receptor(Human)
Bayer Pharma Aktiengesellschaft

US Patent
LigandPNGBDBM521140(US11149023, Example 34)
Affinity DataIC50: 0.820nMAssay Description:The identification of agonists and antagonists of the V1a and V2 vasopressin receptors from humans, rats and dogs as well as the quantification of th...More data for this Ligand-Target Pair
In Depth
Date in BDB:
3/13/2022
Entry Details
Go to US Patent

TargetVasopressin V1a receptor(Human)
Bayer Pharma Aktiengesellschaft

US Patent
LigandPNGBDBM521129(tert-Butyl 3-({3-[3-(4-chlorophenyl)-1-{[1-(3-chlo...)
Affinity DataIC50: 1.01nMAssay Description:The identification of agonists and antagonists of the V1a and V2 vasopressin receptors from humans, rats and dogs as well as the quantification of th...More data for this Ligand-Target Pair
In Depth
Date in BDB:
3/13/2022
Entry Details
Go to US Patent

TargetVasopressin V1a receptor(Human)
Bayer Pharma Aktiengesellschaft

US Patent
LigandPNGBDBM521172(N-{3-[3-(4-Chlorophenyl)-5-oxo-1-({1-[3-(trifluoro...)
Affinity DataIC50: 1.15nMAssay Description:The identification of agonists and antagonists of the V1a and V2 vasopressin receptors from humans, rats and dogs as well as the quantification of th...More data for this Ligand-Target Pair
In Depth
Date in BDB:
3/13/2022
Entry Details
Go to US Patent

TargetVasopressin V1a receptor(Human)
Bayer Pharma Aktiengesellschaft

US Patent
LigandPNGBDBM521138(N-{3-[3-(4-Chlorophenyl)-1-{[1-(3-chloropyridin-2-...)
Affinity DataIC50: 1.17nMAssay Description:The identification of agonists and antagonists of the V1a and V2 vasopressin receptors from humans, rats and dogs as well as the quantification of th...More data for this Ligand-Target Pair
In Depth
Date in BDB:
3/13/2022
Entry Details
Go to US Patent

TargetVasopressin V1a receptor(Human)
Bayer Pharma Aktiengesellschaft

US Patent
LigandPNGBDBM521117(N-{3-[3-(4-Chlorophenyl)-1-{[1-(3-chloropyridin-2-...)
Affinity DataIC50: 1.20nMAssay Description:The identification of agonists and antagonists of the V1a and V2 vasopressin receptors from humans, rats and dogs as well as the quantification of th...More data for this Ligand-Target Pair
In Depth
Date in BDB:
3/13/2022
Entry Details
Go to US Patent

TargetVasopressin V1a receptor(Human)
Bayer Pharma Aktiengesellschaft

US Patent
LigandPNGBDBM521169(N-{3-[3-(4-Chlorophenyl)-5-oxo-1-({1-[3-(trifluoro...)
Affinity DataIC50: 1.20nMAssay Description:The identification of agonists and antagonists of the V1a and V2 vasopressin receptors from humans, rats and dogs as well as the quantification of th...More data for this Ligand-Target Pair
In Depth
Date in BDB:
3/13/2022
Entry Details
Go to US Patent

TargetVasopressin V1a receptor(Human)
Bayer Pharma Aktiengesellschaft

US Patent
LigandPNGBDBM521151(US11149023, Example 46)
Affinity DataIC50: 1.35nMAssay Description:The identification of agonists and antagonists of the V1a and V2 vasopressin receptors from humans, rats and dogs as well as the quantification of th...More data for this Ligand-Target Pair
In Depth
Date in BDB:
3/13/2022
Entry Details
Go to US Patent

TargetVasopressin V1a receptor(Human)
Bayer Pharma Aktiengesellschaft

US Patent
LigandPNGBDBM521148(US11149023, Example 43)
Affinity DataIC50: 1.40nMAssay Description:The identification of agonists and antagonists of the V1a and V2 vasopressin receptors from humans, rats and dogs as well as the quantification of th...More data for this Ligand-Target Pair
In Depth
Date in BDB:
3/13/2022
Entry Details
Go to US Patent

TargetVasopressin V1a receptor(Human)
Bayer Pharma Aktiengesellschaft

US Patent
LigandPNGBDBM521146(N-{3-[3-(4-Chlorophenyl)-1-{[1-(3-chloropyridin-2-...)
Affinity DataIC50: 1.5nMAssay Description:The identification of agonists and antagonists of the V1a and V2 vasopressin receptors from humans, rats and dogs as well as the quantification of th...More data for this Ligand-Target Pair
In Depth
Date in BDB:
3/13/2022
Entry Details
Go to US Patent

TargetVasopressin V1a receptor(Human)
Bayer Pharma Aktiengesellschaft

US Patent
LigandPNGBDBM521158(N-{3-[3-(4-Chlorophenyl)-1-{[1-(3-chloropyridin-2-...)
Affinity DataIC50: 1.60nMAssay Description:The identification of agonists and antagonists of the V1a and V2 vasopressin receptors from humans, rats and dogs as well as the quantification of th...More data for this Ligand-Target Pair
In Depth
Date in BDB:
3/13/2022
Entry Details
Go to US Patent

TargetVasopressin V1a receptor(Human)
Bayer Pharma Aktiengesellschaft

US Patent
LigandPNGBDBM521167(N-{3-[3-(4-Chlorophenyl)-5-oxo-1-({1-[3-(trifluoro...)
Affinity DataIC50: 1.60nMAssay Description:The identification of agonists and antagonists of the V1a and V2 vasopressin receptors from humans, rats and dogs as well as the quantification of th...More data for this Ligand-Target Pair
In Depth
Date in BDB:
3/13/2022
Entry Details
Go to US Patent

TargetVasopressin V1a receptor(Human)
Bayer Pharma Aktiengesellschaft

US Patent
LigandPNGBDBM521113(N-{3-[3-(4-Chlorophenyl)-1-{[1-(3-chloropyridin-2-...)
Affinity DataIC50: 1.65nMAssay Description:The identification of agonists and antagonists of the V1a and V2 vasopressin receptors from humans, rats and dogs as well as the quantification of th...More data for this Ligand-Target Pair
In Depth
Date in BDB:
3/13/2022
Entry Details
Go to US Patent

TargetVasopressin V1a receptor(Human)
Bayer Pharma Aktiengesellschaft

US Patent
LigandPNGBDBM521143(N-{3-[3-(4-Chlorophenyl)-1-{[1-(3-chloropyridin-2-...)
Affinity DataIC50: 1.70nMAssay Description:The identification of agonists and antagonists of the V1a and V2 vasopressin receptors from humans, rats and dogs as well as the quantification of th...More data for this Ligand-Target Pair
In Depth
Date in BDB:
3/13/2022
Entry Details
Go to US Patent

TargetVasopressin V1a receptor(Human)
Bayer Pharma Aktiengesellschaft

US Patent
LigandPNGBDBM521131((2E)-N-{3-[3-(4-Chlorophenyl)-1-{[1-(3-chloropyrid...)
Affinity DataIC50: 1.75nMAssay Description:The identification of agonists and antagonists of the V1a and V2 vasopressin receptors from humans, rats and dogs as well as the quantification of th...More data for this Ligand-Target Pair
In Depth
Date in BDB:
3/13/2022
Entry Details
Go to US Patent

TargetVasopressin V1a receptor(Human)
Bayer Pharma Aktiengesellschaft

US Patent
LigandPNGBDBM521149(N-{3-[3-(4-Chlorophenyl)-1-{[1-(3-chloropyridin-2-...)
Affinity DataIC50: 1.75nMAssay Description:The identification of agonists and antagonists of the V1a and V2 vasopressin receptors from humans, rats and dogs as well as the quantification of th...More data for this Ligand-Target Pair
In Depth
Date in BDB:
3/13/2022
Entry Details
Go to US Patent

TargetVasopressin V1a receptor(Human)
Bayer Pharma Aktiengesellschaft

US Patent
LigandPNGBDBM521134(tert-Butyl [1-({3-[3-(4-chlorophenyl)-1-{[1-(3-chl...)
Affinity DataIC50: 1.85nMAssay Description:The identification of agonists and antagonists of the V1a and V2 vasopressin receptors from humans, rats and dogs as well as the quantification of th...More data for this Ligand-Target Pair
In Depth
Date in BDB:
3/13/2022
Entry Details
Go to US Patent

TargetVasopressin V1a receptor(Human)
Bayer Pharma Aktiengesellschaft

US Patent
LigandPNGBDBM521152(N-{3-[3-(4-Chlorophenyl)-1-{[1-(3-chloropyridin-2-...)
Affinity DataIC50: 1.85nMAssay Description:The identification of agonists and antagonists of the V1a and V2 vasopressin receptors from humans, rats and dogs as well as the quantification of th...More data for this Ligand-Target Pair
In Depth
Date in BDB:
3/13/2022
Entry Details
Go to US Patent

TargetVasopressin V1a receptor(Human)
Bayer Pharma Aktiengesellschaft

US Patent
LigandPNGBDBM521164(N-{3-[3-(4-Chlorophenyl)-5-oxo-1-({1-[3-(trifluoro...)
Affinity DataIC50: 1.90nMAssay Description:The identification of agonists and antagonists of the V1a and V2 vasopressin receptors from humans, rats and dogs as well as the quantification of th...More data for this Ligand-Target Pair
In Depth
Date in BDB:
3/13/2022
Entry Details
Go to US Patent

TargetVasopressin V1a receptor(Human)
Bayer Pharma Aktiengesellschaft

US Patent
LigandPNGBDBM521160(N-{3-[3-(4-Chlorophenyl)-1-{[1-(3-chloropyridin-2-...)
Affinity DataIC50: 1.95nMAssay Description:The identification of agonists and antagonists of the V1a and V2 vasopressin receptors from humans, rats and dogs as well as the quantification of th...More data for this Ligand-Target Pair
In Depth
Date in BDB:
3/13/2022
Entry Details
Go to US Patent

TargetVasopressin V1a receptor(Human)
Bayer Pharma Aktiengesellschaft

US Patent
LigandPNGBDBM521174(N-{3-[3-(4-Chlorophenyl)-5-oxo-1-({1-[3-(trifluoro...)
Affinity DataIC50: 1.95nMAssay Description:The identification of agonists and antagonists of the V1a and V2 vasopressin receptors from humans, rats and dogs as well as the quantification of th...More data for this Ligand-Target Pair
In Depth
Date in BDB:
3/13/2022
Entry Details
Go to US Patent

TargetVasopressin V1a receptor(Human)
Bayer Pharma Aktiengesellschaft

US Patent
LigandPNGBDBM521121(N-{3-[3-(4-Chlorophenyl)-1-{[1-(3-chloropyridin-2-...)
Affinity DataIC50: 2.05nMAssay Description:The identification of agonists and antagonists of the V1a and V2 vasopressin receptors from humans, rats and dogs as well as the quantification of th...More data for this Ligand-Target Pair
In Depth
Date in BDB:
3/13/2022
Entry Details
Go to US Patent

TargetVasopressin V1a receptor(Human)
Bayer Pharma Aktiengesellschaft

US Patent
LigandPNGBDBM521125(N-{3-[3-(4-Chlorophenyl)-1-{[1-(3-chloropyridin-2-...)
Affinity DataIC50: 2.20nMAssay Description:The identification of agonists and antagonists of the V1a and V2 vasopressin receptors from humans, rats and dogs as well as the quantification of th...More data for this Ligand-Target Pair
In Depth
Date in BDB:
3/13/2022
Entry Details
Go to US Patent

TargetVasopressin V1a receptor(Human)
Bayer Pharma Aktiengesellschaft

US Patent
LigandPNGBDBM521124(N-{3-[3-(4-Chlorophenyl)-1-{[1-(3-chloropyridin-2-...)
Affinity DataIC50: 2.5nMAssay Description:The identification of agonists and antagonists of the V1a and V2 vasopressin receptors from humans, rats and dogs as well as the quantification of th...More data for this Ligand-Target Pair
In Depth
Date in BDB:
3/13/2022
Entry Details
Go to US Patent

TargetVasopressin V1a receptor(Human)
Bayer Pharma Aktiengesellschaft

US Patent
LigandPNGBDBM521157(5-Chloro-N-{3-[3-(4-chlorophenyl)-1-{[1-(3-chlorop...)
Affinity DataIC50: 2.80nMAssay Description:The identification of agonists and antagonists of the V1a and V2 vasopressin receptors from humans, rats and dogs as well as the quantification of th...More data for this Ligand-Target Pair
In Depth
Date in BDB:
3/13/2022
Entry Details
Go to US Patent

TargetVasopressin V1a receptor(Human)
Bayer Pharma Aktiengesellschaft

US Patent
LigandPNGBDBM521156(N-{3-[3-(4-Chlorophenyl)-1-{[1-(3-chloropyridin-2-...)
Affinity DataIC50: 2.90nMAssay Description:The identification of agonists and antagonists of the V1a and V2 vasopressin receptors from humans, rats and dogs as well as the quantification of th...More data for this Ligand-Target Pair
In Depth
Date in BDB:
3/13/2022
Entry Details
Go to US Patent

TargetVasopressin V1a receptor(Human)
Bayer Pharma Aktiengesellschaft

US Patent
LigandPNGBDBM521163(N-{3-[3-(4-Chlorophenyl)-5-oxo-1-({1-[3-(trifluoro...)
Affinity DataIC50: 3nMAssay Description:The identification of agonists and antagonists of the V1a and V2 vasopressin receptors from humans, rats and dogs as well as the quantification of th...More data for this Ligand-Target Pair
In Depth
Date in BDB:
3/13/2022
Entry Details
Go to US Patent

TargetVasopressin V1a receptor(Human)
Bayer Pharma Aktiengesellschaft

US Patent
LigandPNGBDBM521155(N-{3-[3-(4-Chlorophenyl)-1-{[1-(3-chloropyridin-2-...)
Affinity DataIC50: 3.20nMAssay Description:The identification of agonists and antagonists of the V1a and V2 vasopressin receptors from humans, rats and dogs as well as the quantification of th...More data for this Ligand-Target Pair
In Depth
Date in BDB:
3/13/2022
Entry Details
Go to US Patent

TargetVasopressin V1a receptor(Human)
Bayer Pharma Aktiengesellschaft

US Patent
LigandPNGBDBM521154(N-{3-[3-(4-Chlorophenyl)-1-{[1-(3-chloropyridin-2-...)
Affinity DataIC50: 3.35nMAssay Description:The identification of agonists and antagonists of the V1a and V2 vasopressin receptors from humans, rats and dogs as well as the quantification of th...More data for this Ligand-Target Pair
In Depth
Date in BDB:
3/13/2022
Entry Details
Go to US Patent

TargetVasopressin V1a receptor(Human)
Bayer Pharma Aktiengesellschaft

US Patent
LigandPNGBDBM521137(N-{3-[3-(4-Chlorophenyl)-1-{[1-(3-chloropyridin-2-...)
Affinity DataIC50: 3.40nMAssay Description:The identification of agonists and antagonists of the V1a and V2 vasopressin receptors from humans, rats and dogs as well as the quantification of th...More data for this Ligand-Target Pair
In Depth
Date in BDB:
3/13/2022
Entry Details
Go to US Patent

TargetVasopressin V1a receptor(Human)
Bayer Pharma Aktiengesellschaft

US Patent
LigandPNGBDBM521141(US11149023, Example 36)
Affinity DataIC50: 3.5nMAssay Description:The identification of agonists and antagonists of the V1a and V2 vasopressin receptors from humans, rats and dogs as well as the quantification of th...More data for this Ligand-Target Pair
In Depth
Date in BDB:
3/13/2022
Entry Details
Go to US Patent

TargetVasopressin V1a receptor(Human)
Bayer Pharma Aktiengesellschaft

US Patent
LigandPNGBDBM521159(tert-Butyl 2-({3-[3-(4-chlorophenyl)-1-{[1-(3-chlo...)
Affinity DataIC50: 3.90nMAssay Description:The identification of agonists and antagonists of the V1a and V2 vasopressin receptors from humans, rats and dogs as well as the quantification of th...More data for this Ligand-Target Pair
In Depth
Date in BDB:
3/13/2022
Entry Details
Go to US Patent

TargetVasopressin V1a receptor(Human)
Bayer Pharma Aktiengesellschaft

US Patent
LigandPNGBDBM521128(N-{3-[3-(4-Chlorophenyl)-1-{[1-(3-chloropyridin-2-...)
Affinity DataIC50: 4.05nMAssay Description:The identification of agonists and antagonists of the V1a and V2 vasopressin receptors from humans, rats and dogs as well as the quantification of th...More data for this Ligand-Target Pair
In Depth
Date in BDB:
3/13/2022
Entry Details
Go to US Patent

TargetVasopressin V1a receptor(Human)
Bayer Pharma Aktiengesellschaft

US Patent
LigandPNGBDBM521109(N-{3-[3-(4-Chlorophenyl)-1-{[1-(3-chloropyridin-2-...)
Affinity DataIC50: 4.10nMAssay Description:The identification of agonists and antagonists of the V1a and V2 vasopressin receptors from humans, rats and dogs as well as the quantification of th...More data for this Ligand-Target Pair
In Depth
Date in BDB:
3/13/2022
Entry Details
Go to US Patent

TargetVasopressin V1a receptor(Human)
Bayer Pharma Aktiengesellschaft

US Patent
LigandPNGBDBM521130(N-{3-[3-(4-Chlorophenyl)-1-{[1-(3-chloropyridin-2-...)
Affinity DataIC50: 4.40nMAssay Description:The identification of agonists and antagonists of the V1a and V2 vasopressin receptors from humans, rats and dogs as well as the quantification of th...More data for this Ligand-Target Pair
In Depth
Date in BDB:
3/13/2022
Entry Details
Go to US Patent

TargetVasopressin V1a receptor(Human)
Bayer Pharma Aktiengesellschaft

US Patent
LigandPNGBDBM521107(N-{3-[3-(4-Chlorophenyl)-1-{[1-(3-chloropyridin-2-...)
Affinity DataIC50: 4.90nMAssay Description:The identification of agonists and antagonists of the V1a and V2 vasopressin receptors from humans, rats and dogs as well as the quantification of th...More data for this Ligand-Target Pair
In Depth
Date in BDB:
3/13/2022
Entry Details
Go to US Patent

TargetVasopressin V1a receptor(Human)
Bayer Pharma Aktiengesellschaft

US Patent
LigandPNGBDBM521176(N-{3-[3-(4-Chlorophenyl)-5-oxo-1-({1-[3-(trifluoro...)
Affinity DataIC50: 4.90nMAssay Description:The identification of agonists and antagonists of the V1a and V2 vasopressin receptors from humans, rats and dogs as well as the quantification of th...More data for this Ligand-Target Pair
In Depth
Date in BDB:
3/13/2022
Entry Details
Go to US Patent

TargetVasopressin V1a receptor(Human)
Bayer Pharma Aktiengesellschaft

US Patent
LigandPNGBDBM521122(1-({3-[3-(4-Chlorophenyl)-1-{[1-(3-chloropyridin-2...)
Affinity DataIC50: 5.05nMAssay Description:The identification of agonists and antagonists of the V1a and V2 vasopressin receptors from humans, rats and dogs as well as the quantification of th...More data for this Ligand-Target Pair
In Depth
Date in BDB:
3/13/2022
Entry Details
Go to US Patent

TargetVasopressin V1a receptor(Human)
Bayer Pharma Aktiengesellschaft

US Patent
LigandPNGBDBM521153(N-{3-[3-(4-Chlorophenyl)-1-{[1-(3-chloropyridin-2-...)
Affinity DataIC50: 5.40nMAssay Description:The identification of agonists and antagonists of the V1a and V2 vasopressin receptors from humans, rats and dogs as well as the quantification of th...More data for this Ligand-Target Pair
In Depth
Date in BDB:
3/13/2022
Entry Details
Go to US Patent

TargetVasopressin V1a receptor(Human)
Bayer Pharma Aktiengesellschaft

US Patent
LigandPNGBDBM521171(N-{3-[3-(4-Chlorophenyl)-5-oxo-1-({1-[3-(trifluoro...)
Affinity DataIC50: 5.40nMAssay Description:The identification of agonists and antagonists of the V1a and V2 vasopressin receptors from humans, rats and dogs as well as the quantification of th...More data for this Ligand-Target Pair
In Depth
Date in BDB:
3/13/2022
Entry Details
Go to US Patent

TargetVasopressin V1a receptor(Human)
Bayer Pharma Aktiengesellschaft

US Patent
LigandPNGBDBM521112(N-{3-[3-(4-Chlorophenyl)-1-{[1-(3-chloropyridin-2-...)
Affinity DataIC50: 5.65nMAssay Description:The identification of agonists and antagonists of the V1a and V2 vasopressin receptors from humans, rats and dogs as well as the quantification of th...More data for this Ligand-Target Pair
In Depth
Date in BDB:
3/13/2022
Entry Details
Go to US Patent

TargetVasopressin V1a receptor(Human)
Bayer Pharma Aktiengesellschaft

US Patent
LigandPNGBDBM521135(1-Amino-N-{3-[3-(4-chlorophenyl)-1-{[1-(3-chloropy...)
Affinity DataIC50: 5.65nMAssay Description:The identification of agonists and antagonists of the V1a and V2 vasopressin receptors from humans, rats and dogs as well as the quantification of th...More data for this Ligand-Target Pair
In Depth
Date in BDB:
3/13/2022
Entry Details
Go to US Patent

TargetVasopressin V1a receptor(Human)
Bayer Pharma Aktiengesellschaft

US Patent
LigandPNGBDBM521127(N-{(3-[3-(4-Chlorophenyl)-1-{[1-(3-chloropyridin-2...)
Affinity DataIC50: 5.95nMAssay Description:The identification of agonists and antagonists of the V1a and V2 vasopressin receptors from humans, rats and dogs as well as the quantification of th...More data for this Ligand-Target Pair
In Depth
Date in BDB:
3/13/2022
Entry Details
Go to US Patent

TargetVasopressin V1a receptor(Human)
Bayer Pharma Aktiengesellschaft

US Patent
LigandPNGBDBM521116(N-{(3-[3-(4-Chlorophenyl)-1-{[1-(3-chloropyridin-2...)
Affinity DataIC50: 6.10nMAssay Description:The identification of agonists and antagonists of the V1a and V2 vasopressin receptors from humans, rats and dogs as well as the quantification of th...More data for this Ligand-Target Pair
In Depth
Date in BDB:
3/13/2022
Entry Details
Go to US Patent

TargetVasopressin V1a receptor(Human)
Bayer Pharma Aktiengesellschaft

US Patent
LigandPNGBDBM521173(N-{3-[3-(4-Chlorophenyl)-5-oxo-1-({1-[3-(trifluoro...)
Affinity DataIC50: 6.15nMAssay Description:The identification of agonists and antagonists of the V1a and V2 vasopressin receptors from humans, rats and dogs as well as the quantification of th...More data for this Ligand-Target Pair
In Depth
Date in BDB:
3/13/2022
Entry Details
Go to US Patent

TargetVasopressin V1a receptor(Human)
Bayer Pharma Aktiengesellschaft

US Patent
LigandPNGBDBM521136(N-{3-[3-(4-Chlorophenyl)-1-{[1-(3-chloropyridin-2-...)
Affinity DataIC50: 6.30nMAssay Description:The identification of agonists and antagonists of the V1a and V2 vasopressin receptors from humans, rats and dogs as well as the quantification of th...More data for this Ligand-Target Pair
In Depth
Date in BDB:
3/13/2022
Entry Details
Go to US Patent

TargetVasopressin V1a receptor(Human)
Bayer Pharma Aktiengesellschaft

US Patent
LigandPNGBDBM521175(N-{3-[3-(4-Chlorophenyl)-5-oxo-1-({1-[3-(trifluoro...)
Affinity DataIC50: 6.35nMAssay Description:The identification of agonists and antagonists of the V1a and V2 vasopressin receptors from humans, rats and dogs as well as the quantification of th...More data for this Ligand-Target Pair
In Depth
Date in BDB:
3/13/2022
Entry Details
Go to US Patent

TargetVasopressin V1a receptor(Human)
Bayer Pharma Aktiengesellschaft

US Patent
LigandPNGBDBM521119(N-{3-[3-(4-Chlorophenyl)-1-{[1-(3-chloropyridin-2-...)
Affinity DataIC50: 6.95nMAssay Description:The identification of agonists and antagonists of the V1a and V2 vasopressin receptors from humans, rats and dogs as well as the quantification of th...More data for this Ligand-Target Pair
In Depth
Date in BDB:
3/13/2022
Entry Details
Go to US Patent

TargetVasopressin V1a receptor(Human)
Bayer Pharma Aktiengesellschaft

US Patent
LigandPNGBDBM521161(tert-Butyl 2-({3-[3-(4-chlorophenyl)-1-{[1-(3-chlo...)
Affinity DataIC50: 8.10nMAssay Description:The identification of agonists and antagonists of the V1a and V2 vasopressin receptors from humans, rats and dogs as well as the quantification of th...More data for this Ligand-Target Pair
In Depth
Date in BDB:
3/13/2022
Entry Details
Go to US Patent

Displayed 1 to 50 (of 140 total ) | Next | Last >>
Jump to: